Maplight Therapeutics, Common Stock Price Prediction
| MPLT Stock | 17.86 0.26 1.43% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using MapLight Therapeutics, hype-based prediction, you can estimate the value of MapLight Therapeutics, Common from the perspective of MapLight Therapeutics, response to recently generated media hype and the effects of current headlines on its competitors.
MapLight Therapeutics, Hype to Price Pattern
Investor biases related to MapLight Therapeutics,'s public news can be used to forecast risks associated with an investment in MapLight. The trend in average sentiment can be used to explain how an investor holding MapLight can time the market purely based on public headlines and social activities around MapLight Therapeutics, Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MapLight Therapeutics,'s market sentiment to its price can help taders to make decisions based on the overall investors consensus about MapLight Therapeutics,.
The fear of missing out, i.e., FOMO, can cause potential investors in MapLight Therapeutics, to buy its stock at a price that has no basis in reality. In that case, they are not buying MapLight because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MapLight Therapeutics, after-hype prediction price | USD 17.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out MapLight Therapeutics, Basic Forecasting Models to cross-verify your projections. MapLight Therapeutics, After-Hype Price Prediction Density Analysis
As far as predicting the price of MapLight Therapeutics, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MapLight Therapeutics, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MapLight Therapeutics,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MapLight Therapeutics, Estimiated After-Hype Price Volatility
In the context of predicting MapLight Therapeutics,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MapLight Therapeutics,'s historical news coverage. MapLight Therapeutics,'s after-hype downside and upside margins for the prediction period are 11.09 and 24.63, respectively. We have considered MapLight Therapeutics,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MapLight Therapeutics, is slightly risky at this time. Analysis and calculation of next after-hype price of MapLight Therapeutics, is based on 3 months time horizon.
MapLight Therapeutics, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MapLight Therapeutics, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MapLight Therapeutics, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MapLight Therapeutics,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 6.69 | 0.05 | 0.03 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
17.86 | 17.86 | 0.00 |
|
MapLight Therapeutics, Hype Timeline
MapLight Therapeutics, is now traded for 17.86. The entity has historical hype elasticity of 0.05, and average elasticity to hype of competition of 0.03. MapLight is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 0.14%. %. The volatility of related hype on MapLight Therapeutics, is about 3716.67%, with the expected price after the next announcement by competition of 17.89. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out MapLight Therapeutics, Basic Forecasting Models to cross-verify your projections.MapLight Therapeutics, Related Hype Analysis
Having access to credible news sources related to MapLight Therapeutics,'s direct competition is more important than ever and may enhance your ability to predict MapLight Therapeutics,'s future price movements. Getting to know how MapLight Therapeutics,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MapLight Therapeutics, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ESLA | Estrella Immunopharma | 0.62 | 7 per month | 8.43 | 0.09 | 16.52 | (14.69) | 50.95 | |
| VTVT | vTv Therapeutics | 0.15 | 4 per month | 3.42 | 0.19 | 7.40 | (6.27) | 19.57 | |
| TELO | Telomir Pharmaceuticals, Common | (0.13) | 8 per month | 4.80 | (0.01) | 5.73 | (8.00) | 41.27 | |
| FBIO | Fortress Biotech | (0.15) | 11 per month | 6.13 | 0.02 | 6.63 | (5.13) | 35.08 | |
| ICCC | ImmuCell | 0.08 | 8 per month | 0.00 | (0.04) | 5.49 | (6.63) | 16.62 | |
| MRSN | Mersana Therapeutics | 0.71 | 8 per month | 2.33 | 0.14 | 7.25 | (6.26) | 210.61 | |
| BTAI | BioXcel Therapeutics | (0.10) | 5 per month | 0.00 | (0.1) | 8.90 | (8.44) | 24.65 | |
| TPST | Tempest Therapeutics | 0.26 | 9 per month | 0.00 | (0.14) | 8.85 | (9.56) | 60.86 |
MapLight Therapeutics, Additional Predictive Modules
Most predictive techniques to examine MapLight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MapLight using various technical indicators. When you analyze MapLight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MapLight Therapeutics, Predictive Indicators
The successful prediction of MapLight Therapeutics, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MapLight Therapeutics, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MapLight Therapeutics, based on analysis of MapLight Therapeutics, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MapLight Therapeutics,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MapLight Therapeutics,'s related companies. | 2010 | 2023 | 2024 | 2025 (projected) | PB Ratio | 36.41 | 10.66 | 6.6 | 6.27 | Capex To Depreciation | 1.3 | 0.83 | 1.1 | 1.19 |
Story Coverage note for MapLight Therapeutics,
The number of cover stories for MapLight Therapeutics, depends on current market conditions and MapLight Therapeutics,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MapLight Therapeutics, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MapLight Therapeutics,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics,'s price analysis, check to measure MapLight Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics, is operating at the current time. Most of MapLight Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics,'s price. Additionally, you may evaluate how the addition of MapLight Therapeutics, to your portfolios can decrease your overall portfolio volatility.